Securities code: 688289 Securities abbreviation: Shengxiang Biological Announcement No.: 2023-012.

Shengxiang Biotechnology Co., Ltd. holds more than 5% shares.

Announcement on the Results of Shareholders' Centralized Bidding for Shareholding Reduction

The board of directors, all directors and relevant shareholders of the Company guarantee that there are no false records in the contents of this announcement,

misleading statements or material omissions, and shall be legally liable for the truthfulness, accuracy and completeness of their contents.

Responsibility.

Important Content Tips:

Basic information on shareholder holdings

Prior to the implementation of this reduction plan, Anhui Zhidao Investment Co., Ltd. (hereinafter referred to as "Anhui Zhidao") held

29,987,768 shares of Shengxiang Biotechnology Co., Ltd. (hereinafter referred to as "Shengxiang Biotechnology" or the "Company"),

It accounts for 5.10 per cent of the company's total shares, and its shares are the shares of the company prior to its initial public offering and listing on the board.

shares, which have been listed for circulation since August 30, 2021.

The results of the implementation of the centralized bidding reduction plan.

On August 17, 2022, the company disclosed that "Shengxiang Biotechnology Co., Ltd. holds more than 5% of the shares."

Announcement on the Plan for Shareholders' Centralized Bidding to Reduce Their Shares (Announcement No. 2022-068), Anhui Zhidao intends to adopt the centralized

The auction transaction reduces its holdings of Shengxiang Bio shares by no more than 11,769,196 shares. Company in 2023

On March 3, 2012, Anhui Zhidao received a notification letter from Anhui Zhidao, and as of March 3, 2023, Anhui Zhidao passed

The centralized bidding transaction method has reduced the company's shares by 11,696,800 shares, accounting for 1.99 of the company's total share capital.

The second reduction plan has been implemented.

1. centralized bidding to reduce the reduction of the main body before the basic situation.

Name of shareholder Identity of shareholder Number of shares held (shares) Percentage of shares currently held Source of shares

Anhui Zhidao 5% + Non-First 29,987,768 5.10 Pre-IPO: 29,987,768

Major shareholder shares

The above-mentioned reduction subject has no concerted action person.

Results of the Implementation of the Centralized Bidding Reduction Plan in 2.

(I) major shareholders disclose the results of the implementation of the centralized bidding reduction plan for the following matters:

Other circumstances: early termination of the reduction plan.

Number of shares to be reduced Price area Total amount of shares to be reduced Completion of shares to be held Current shares to be held

Name of shareholder (shares) Reduction ratio Reduction period Reduction method (yuan) Number ratio

($/share) (shares)

Anhui Zhidao 11,696,800 1.99 2022/9/9 ~ Centralized Bidding 22.66-26.36 285,412,127.97 Incomplete: 5,958,967 1.01%

2023/1/19 Trading 72,396 Shares

(II) whether the actual reduction is consistent with the previously disclosed reduction plan and commitment √ Yes □ No

(III) the expiration of the time interval for the reduction of holdings, whether the reduction has not been implemented.

Whether the actual reduction of (IV) has not reached the minimum reduction of the reduction plan (proportion).

Whether the (V) terminates the reduction plan early √ Yes □ No

Shareholders due to their own reduction arrangements, decided to terminate the reduction plan.

It is hereby announced.

Shengxiang Biotechnology Co., Ltd.

Board of Directors

March 4, 2023